A placebo controlled clinical trial on the efficacy of atorvastatin 20 mg daily administration for 4-6 weeks in patients with bronchial hyper-responsiveness.
Phase of Trial: Phase I/II
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Atorvastatin (Primary)
- Indications Bronchial disorders
- Focus Therapeutic Use
- 26 Aug 2009 New trial record